Results

Total Results: 485 records

Showing results for "breast".
Users also searched for: breast cancer

141. U.S. Preventive Services Task Force Issues Final Recommendation Statement for Medications for Risk Reduction of Primary Breast Cancer in Women | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-recommendation-statement-medications-risk-reduction-primary-breast-cancer-women
     September 24, 2013 - Services Task Force Issues Final Recommendation Statement for Medications for Risk Reduction of Primary Breast … Force released today a final recommendation statement on medications for risk reduction of primary breast … view the recommendation and the evidence on which it is based, please go to  /uspstf/recommendation/breast-cancer-medications-for-risk-reduction

142. Cc7S5Lxbfmohh5Zmmxjwkm (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CC7S5LxbFmoHh5ZmMxJWkM
     February 01, 2016 - screening (61% vs. 42% and 7% vs. 5%, respectively) and for women aged 40 to 49 years, those with dense breasts … False-positive results are common and are higher for annual screening, younger women, and women with dense breasts … mam- mography results were highest among women receiv- ing annual mammography who had extremely dense breasts … lower among women aged 50 to 74 years who were receiving biennial or triennial mammography and had breasts … Adjunctive Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S.

143. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer in Women (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qX9C7hyCBCNRjptQNCa_37
     December 01, 2013 - statement applies to women who have no signs or symptoms of a BRCA- related cancer (cancer of the breast … BRCA stands for “BReast CAncer susceptibility gene.” … About 3 percent of American women die from breast cancer, and about 1 percent die from ovarian cancer … treatments include frequent cancer screening, risk-reducing medications, or surgery to remove her breasts … Breast or Ovarian Cancer Runs in Your Family (healthfinder.gov) Genetic Testing for Breast and

144. Pgytn Cwqnmar9-3Du5Ste (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/PGYTn_cWQnmAr9-3du5StE
     February 01, 2016 - fat and scattered fi- broglandular densities or extremely dense breasts in all age groups except 80 … dense breasts. … dense breasts or those in the combined category of heterogeneous and extreme density. … Women with ex- tremely dense breasts had the highest rates of false- negative results. … Identifying women with dense breasts at high risk for interval cancer: a cohort study.

145. Public Comment on Draft Recommendation Statement: Screening for Breast Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-screening-breast-cancer
     May 18, 2015 - Public Comment on Draft Recommendation Statement: Screening for Breast Cancer Share to … Task Force posted its draft recommendation statement and draft evidence documents on screening for breast

146. Public Comment on Draft Research Plan: Screening for Breast Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-screening-breast-cancer
     December 11, 2013 - Public Comment on Draft Research Plan: Screening for Breast Cancer Share to Facebook … Preventive Services Task Force posted today for public comment a draft Research Plan on screening for breast

147. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RGu5KsFRY2YEAsDC9EQox9
     December 31, 2013 - history factors associated with increased likelihood of potentially harmful BRCA mutations include breast … cancer diagnosis before age 50 years, bilateral breast cancer, family history of breast and ovarian … cancer, presence of breast cancer in ≥1 male family member, multiple cases of breast cancer in the … Relevant USPSTF Recommendations The USPSTF has made recommendations on medications for the reduction of breast

148. Archived: Postmenopausal Hormone Prophylaxis: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/postmenopausal-hormone-prophylaxis-preventive-medication-1996
     January 01, 1996 - Breast Cancer Endogenous estrogen appears to be important in the etiology of breast cancer, but the … Menopausal estrogen replacement therapy and breast cancer. … Menopausal hormone replacement therapy and breast cancer: a meta-analysis. … Noncontraceptive hormone use and risk of breast cancer. … Combined oestrogen-progestogen replacement and breast cancer risk.

149. Public Comment on Draft Research Plan: Medication to Reduce the Risk of Breast Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-medication-reduce-risk-breast-cancer
     January 31, 2024 - Public Comment on Draft Research Plan: Medication to Reduce the Risk of Breast Cancer Share … Preventive Services Task Force posted today a draft research plan on medication to reduce the risk of breast

150. Public Comment on Draft Research Plan: Screening for Breast Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-screening-breast-cancer-0
     February 17, 2021 - Public Comment on Draft Research Plan: Screening for Breast Cancer Share to Facebook … Preventive Services Task Force posted today a draft research plan on screening for breast cancer.

151. Archived: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2012
     October 15, 2012 - evidence of a small increase in breast cancer deaths. … Invasive breast cancer. … history of breast cancer or a personal history of breast biopsy. … cell apoptosis because of changes in breast tumor gene expression profiles. … Changing concepts: menopausal hormone therapy and breast cancer.

152. Draft Recommendation: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breastfeeding-interventions
     October 22, 2024 - and feeding expressed breast milk through a bottle. … milk lasts), and exclusivity (consumption of only breast milk, whether from the breast or bottle, … or donor breast milk. … group experienced fewer breastfeeding problems or difficulties (such as mastitis or sore nipples or breasts … Fact Sheet #73: FLSA Protections for Employees to Pump Breast Milk at Work.

153. Final Evidence Review: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - to WhatsApp Share to Email Print Final Evidence Review Breast … Expand All Panel 1 Medication Use for the Risk Reduction of Primary Breast

154. Breastcanfinalrsbulletin (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breastcanfinalrsbulletin.pdf
     January 12, 2016 - Preventive Services Task Force Issues Final Recommendations on Screening for Breast Cancer Task Force … Preventive Services Task Force today published a final recommendation statement on screening for breast … None of the studies of breast cancer screening included women in this age group. … to determine the balance of benefits and harms in two additional areas: screening women with dense breasts … ; and the effectiveness of 3D mammography for the detection of breast cancer.

155. Archived: Final Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan11/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
     December 15, 2012 - or ovarian cancer; and/or long-term health outcomes such as reduced breast or ovarian cancer mortality … BRCA-related cancer = predominantly breast, ovarian, fallopian tube, and peritoneal cancer. … Interventions include intensive screening (earlier and more frequent mammography, breast MRI), use of … Disease/Condition Deleterious BRCA mutation carrier; BRCA-related cancer (predominantly breast … Outcomes Invasive breast cancer, invasive ovarian cancer, other BRCA-related cancer (fallopian

156. Archived: Final Evidence Summary: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
     May 29, 2012 - decreased risk for breast cancer. … increase risk for breast cancer. … Invasive breast, lung, and endometrial cancer were not increased in HERSII 53 . … disease or a family history of breast cancer 63 . … alone decreases risk for breast cancer.

157. USPSTF Issues Draft Recommendation Statement: Genetic Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/brgenbulletin.pdf
     April 02, 2013 - “Every year, too many American women and families are faced with the challenge of dealing with breast … Women with these potentially harmful mutations have a 70 percent chance of developing breast cancer, … “Breast and ovarian cancer are serious health issues and finding better ways to prevent and treat these … “Evaluating for risk of hereditary breast and ovarian cancer syndrome is an important step in cancer … who have family members with breast or ovarian cancer whose BRCA status is unknown.

158. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/v2-menopausal-hormone-therapy-preventive-medicatio
     May 09, 2005 - cancer, ovarian cancer, or colorectal cancer as well as breast cancer mortality or all-cause mortality … However, no effect on breast cancer mortality was observed. … Breast cancer and hormone-replacement therapy in the Million Women Study. … The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. … a family history of breast cancer.

159. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2002-2005
     May 09, 2005 - cancer, ovarian cancer, or colorectal cancer as well as breast cancer mortality or all-cause mortality … However, no effect on breast cancer mortality was observed. … Breast cancer and hormone-replacement therapy in the Million Women Study. … The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. … a family history of breast cancer.

160. Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9NcVWwGErrH9b9M_6NryW
     May 01, 2005 - the effects of combined estrogen and progestin on the incidence of ovarian cancer, mortality from breast … However, no effect on breast cancer mortality was observed. … Breast cancer and hormone- replacement therapy in the Million Women Study. … The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. … with a family history of breast cancer.